Welcome to LookChem.com Sign In|Join Free

CAS

  • or

637039-01-1

Post Buying Request

637039-01-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

637039-01-1 Usage

General Description

Tert-butyl 6-oxa-2,9-diazaspiro[4.5]decane-9-carboxylate is a chemical compound with a complex structure. It is a derivative of spiro compounds, which are a class of organic molecules with a unique carbon framework. The presence of a tert-butyl group and an oxo group in its structure suggests that it is likely to be used as an intermediate in organic synthesis, particularly in pharmaceutical and agrochemical research. The presence of the carboxylate functional group indicates that it may have potential as a building block for the synthesis of organic compounds. tert-butyl 6-oxa-2,9-diazaspiro[4.5]decane-9-carboxylate has the potential for diverse applications due to its unique structure and functional groups, making it a valuable target for further research and development.

Check Digit Verification of cas no

The CAS Registry Mumber 637039-01-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,3,7,0,3 and 9 respectively; the second part has 2 digits, 0 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 637039-01:
(8*6)+(7*3)+(6*7)+(5*0)+(4*3)+(3*9)+(2*0)+(1*1)=151
151 % 10 = 1
So 637039-01-1 is a valid CAS Registry Number.

637039-01-1Downstream Products

637039-01-1Relevant articles and documents

5-MEMBERED HETEROARYLAMINOSULFONAMIDES FOR TREATING CONDITIONS MEDIATED BY DEFICIENT CFTR ACTIVITY

-

Page/Page column 439, (2021/05/21)

The invention relates to heteroaryl compounds, pharmaceutically acceptable salts thereof, and pharmaceutical preparations thereof. Also described herein are compositions and the use of such compounds in methods of treating diseases and conditions mediated by deficient CFTR activity, in particular cystic fibrosis.

NOVEL 2,5-DISUBSTITUTED PYRIMIDINE DERIVATIVES

-

Page/Page column 36-37, (2010/02/06)

The invention relates to novel 2,5-disubstituted pyrimidine derivatives, which stimulate the soluble guanylate cyclase, method for production and use thereof for the production of medicaments, in particular medicaments for the treatment of central nervous system diseases.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 637039-01-1